Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 ?g/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
The report details the trend, potential and market size of Iron Chelation Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Iron Chelation Drugmarket, defines the market attractiveness level of Iron Chelation Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Iron Chelation Drug industry, describes the types of Iron Chelation Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Iron Chelation Drug market and the development prospects and opportunities of Iron Chelation Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Iron Chelation Drug market in Chapter 13.
By Player:
Novartis (Switzerland)
Natco Pharma (India)
Sun Pharma (India)
Cipla (India)
By Type:
Deferoxamine
Deferiprone
Deferasirox
By End-User:
Transfusional Iron Overload
NTDT Caused Iron Overload
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Iron Chelation Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Iron Chelation Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Iron Chelation Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Iron Chelation Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Iron Chelation Drug Market Analysis and Outlook to 2022
-
7.1 Global Iron Chelation Drug Consumption (2017-2022)
-
7.2 United States Iron Chelation Drug Consumption (2017-2022)
-
7.3 Europe Iron Chelation Drug Consumption (2017-2022)
-
7.4 China Iron Chelation Drug Consumption (2017-2022)
-
7.5 Japan Iron Chelation Drug Consumption (2017-2022)
-
7.6 India Iron Chelation Drug Consumption (2017-2022)
-
7.7 South Korea Iron Chelation Drug Consumption (2017-2022)
8 Region and Country-wise Iron Chelation Drug Market Analysis and Outlook to 2028
-
8.1 Global Iron Chelation Drug Consumption Forecast (2022-2028)
-
8.2 United States Iron Chelation Drug Consumption Forecast (2022-2028)
-
8.3 Europe Iron Chelation Drug Consumption Forecast (2022-2028)
-
8.4 China Iron Chelation Drug Consumption Forecast (2022-2028)
-
8.5 Japan Iron Chelation Drug Consumption Forecast (2022-2028)
-
8.6 India Iron Chelation Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Iron Chelation Drug Consumption Forecast (2022-2028)
9 Global Iron Chelation Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Iron Chelation Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Deferoxamine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Deferiprone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Deferasirox Consumption and Growth Rate (2017-2022)
-
9.2 Global Iron Chelation Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Transfusional Iron Overload Consumption and Growth Rate (2017-2022)
-
9.2.2 Global NTDT Caused Iron Overload Consumption and Growth Rate (2017-2022)
10 Global Iron Chelation Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Iron Chelation Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Deferoxamine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Deferiprone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Deferasirox Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Iron Chelation Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Transfusional Iron Overload Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global NTDT Caused Iron Overload Consumption Forecast and Growth Rate (2022-2028)
11 Global Iron Chelation Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Iron Chelation Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Iron Chelation Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Iron Chelation Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Iron Chelation Drug Market Competitive Analysis
-
14.1 Novartis (Switzerland)
-
14.1.1 Novartis (Switzerland) Company Details
-
14.1.2 Novartis (Switzerland) Iron Chelation Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis (Switzerland) Iron Chelation Drug Product and Service
-
14.2 Natco Pharma (India)
-
14.2.1 Natco Pharma (India) Company Details
-
14.2.2 Natco Pharma (India) Iron Chelation Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Natco Pharma (India) Iron Chelation Drug Product and Service
-
14.3 Sun Pharma (India)
-
14.3.1 Sun Pharma (India) Company Details
-
14.3.2 Sun Pharma (India) Iron Chelation Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sun Pharma (India) Iron Chelation Drug Product and Service
-
14.4 Cipla (India)
-
14.4.1 Cipla (India) Company Details
-
14.4.2 Cipla (India) Iron Chelation Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cipla (India) Iron Chelation Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Iron Chelation Drug
-
Figure Iron Chelation Drug Picture
-
Table Global Iron Chelation Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Iron Chelation Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Iron Chelation Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Iron Chelation Drug Consumption by Country (2017-2022)
-
Figure United States Iron Chelation Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Iron Chelation Drug Consumption and Growth Rate (2017-2022)
-
Figure China Iron Chelation Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Iron Chelation Drug Consumption and Growth Rate (2017-2022)
-
Figure India Iron Chelation Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Iron Chelation Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Iron Chelation Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Iron Chelation Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Iron Chelation Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Iron Chelation Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Iron Chelation Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Iron Chelation Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Iron Chelation Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Deferoxamine Consumption and Growth Rate (2017-2022)
-
Figure Global Deferiprone Consumption and Growth Rate (2017-2022)
-
Figure Global Deferasirox Consumption and Growth Rate (2017-2022)
-
Figure Global Transfusional Iron Overload Consumption and Growth Rate (2017-2022)
-
Figure Global NTDT Caused Iron Overload Consumption and Growth Rate (2017-2022)
-
Figure Global Deferoxamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Deferiprone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Deferasirox Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transfusional Iron Overload Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NTDT Caused Iron Overload Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Iron Chelation Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Iron Chelation Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Switzerland) (Foundation Year, Company Profile and etc.)
-
Table Novartis (Switzerland) Iron Chelation Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis (Switzerland) Iron Chelation Drug Product and Service
-
Table Natco Pharma (India) (Foundation Year, Company Profile and etc.)
-
Table Natco Pharma (India) Iron Chelation Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natco Pharma (India) Iron Chelation Drug Product and Service
-
Table Sun Pharma (India) (Foundation Year, Company Profile and etc.)
-
Table Sun Pharma (India) Iron Chelation Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma (India) Iron Chelation Drug Product and Service
-
Table Cipla (India) (Foundation Year, Company Profile and etc.)
-
Table Cipla (India) Iron Chelation Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla (India) Iron Chelation Drug Product and Service
-
